Product How it works Pricing Blog FAQ About Contact
Eli Lilly

Eli Lilly (NYSE: LLY) revenue

Eli Lilly reported revenue of $65,179m for fiscal 2025, 44.7% more than in fiscal 2024 ($45,043m). Since fiscal 2016 its revenue has grown by 207.1%, an average growth of 13.3% a year.

Revenue, in millions of US dollars21,222201619,974201721,493201822,320201924,540202028,318202128,541202234,124202345,043202465,1792025

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$65,179m+44.7%$26,626m40.9%
2024$45,043m+32.0%$13,461m29.9%
2023$34,124m+19.6%$7,040m20.6%
2022$28,541m+0.8%$7,138m25.0%
2021$28,318m+15.4%$6,495m22.9%
2020$24,540m+9.9%$7,590m30.9%
2019$22,320m+3.8%$5,667m25.4%
2018$21,493m+7.6%$3,923m18.3%
2017$19,974m−5.9%$2,530m12.7%
2016$21,222m—$3,559m16.8%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Questions about the revenue of Eli Lilly

How much revenue did Eli Lilly make in fiscal 2025?
Eli Lilly reported revenue of $65,179m for fiscal 2025, compared with $45,043m in fiscal 2024.
How much has the revenue of Eli Lilly grown?
Between fiscal 2016 and fiscal 2025 it went from $21,222m to $65,179m: 207.1% more, an average growth of 13.3% a year.
What was the best year for revenue at Eli Lilly?
Of its last 10 fiscal years, fiscal 2025, with $65,179m.
Where do the figures for Eli Lilly come from?
From the annual report (Form 10-K) that Eli Lilly files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Eli Lilly files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Eli Lilly: the Eli Lilly page · annual accounts · net income · dividends paid · insider transactions.

Dividend per share of Eli Lilly by fiscal year, with the filing behind every figure: Eli Lilly dividend history.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.